(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NICOVAPE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NICOVAPE

ST13

US500000079327091

Class

5, 10

Filing

79327091

Registration

7002631

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

08/01/2023

Trademark type

Word

Nice classes

5, 10

Filing date

07/19/2021

Registration date

03/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/21/2023

Last transaction

03/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

82

Owner location

AU

Examiner

NEAL, KELLY

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LIBER PHARMACEUTICALS PTY LTD

Representatives

Jennifer A. Visintine Thompson Coburn LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for pharmaceutical purposesnamely for the treatment of smoking and nicotine cessation; chemicals for pharmaceutical usenamely for the treatment of smoking and nicotine cessation; chemical products for pharmaceutical usechemical preparations for the treatment of smoking and nicotine cessation; chemical products for medical usenamely for the treatment of smoking and nicotine cessation; dietetic preparations adapted for medical use; drugs for medical purposesnamely drugs for the treatment of smoking and nicotine cessation; imitation cigarettes for quitting smoking; medicaments in liquid form for the treatment of smoking and nicotine cessation; medicated preparations for the treatment of smoking and nicotine cessation; medicated preparations for use as anti-smoking devices; pharmaceutical compositions for the treatment of smoking and nicotine cessation; pharmaceutical preparations for the treatment of smoking and nicotine cessation; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical products for the treatment of smoking and nicotine cessation; pharmaceutical substances for the treatment of smoking and nicotine cessation; tobacco substitutes for medical purposesnamely for the treatment of smoking and nicotine cessation; tobacco-free cigarettes for medical purposesnamely for the treatment of smoking and nicotine cessation

Class 10

Apparatus for administering medicinesnamely medical apparatus for the inhalation of pharmaceutical preparations; apparatus for administering pharmaceuticalsnamely medical apparatus for the inhalation of pharmaceuticals; apparatus for drug administrationnamely medical apparatus for the inhalation of pharmaceutical preparations; medical apparatus for facilitating the inhalation of pharmaceutical preparations; apparatus for medical purposesnamely medical apparatus for facilitating the inhalation of pharmaceutical preparations; medical devices for use in the administration of medicinesnamely devices for the inhalation of pharmaceutical preparations; medical devices for use in the administration of pharmaceuticalsnamely for the inhalation of pharmaceutical preparations; electronic cigarettes for medical purposes; electronic therapeutic devicesnamely electronic cigarettes and vaporizers for medical and therapeutic use; inhalation apparatus for medical use for pharmaceutical preparations; medical apparatusnamely inhalation devices for medical use; pharmaceutical apparatus for the inhalation of pharmaceutical preparations; vaporizers for medical purposes

Publications

History of USPTO decisions and trademark events.

24 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/01/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/11/2023

FIMP

FINAL DISPOSITION PROCESSED

07/11/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/21/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/03/2023

PUBO

PUBLISHED FOR OPPOSITION

01/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/14/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/30/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/29/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/28/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/28/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/17/2022

RFNT

REFUSAL PROCESSED BY IB

06/22/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/01/2022

RFRR

REFUSAL PROCESSED BY MPU

06/01/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/27/2022

CNRT

NON-FINAL ACTION WRITTEN

04/26/2022

DOCK

ASSIGNED TO EXAMINER

04/11/2022

MAFR

APPLICATION FILING RECEIPT MAILED

12/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/13/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

12/11/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/02/2021

Continuous trademark protection

Get notified about every new filing that threatens NICOVAPE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.